HBCM
CVAC

Heron Bay Capital Management’s CureVac CVAC Stock Holding History

Heron Bay Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,213
Closed -$42.1K – 121
2025
Q1 		$42.1K Buy
+15,213
New +$52.9K 0.01% 111

Other funds holding CVAC

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Heron Bay Capital Management's CVAC Position: Q2 2025 in Review

Heron Bay Capital Management sold out of CureVac (CVAC) in Q2 2025, closing a stake of 15,213 shares — an estimated $42.1K sold.

Heron Bay Capital Management first reported a position in CVAC in Q1 2025 and held it in 1 quarter. The position peaked at $42.1K in Q1 2025. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

  • Heron Bay Capital Management reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
  • Heron Bay Capital Management sold 15,213 CureVac shares in Q2 2025, an estimated $42.1K.
  • Heron Bay Capital Management first reported a position in CureVac in Q1 2025 and held it in 1 quarter.
  • Heron Bay Capital Management's CureVac position peaked at $42.1K in Q1 2025.
  • 91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Heron Bay Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.